Delivery Order SPE2DB24D2109-SPE2DB26FHVUM
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,027.44 for Fycompa 8 mg tablets (30-count) with an ultimate completion date of September 5, 2025. This competitive delivery order, issued under firm fixed-price terms with no set-aside designation, represents a single pharmaceutical supply transaction fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, valued at $1,489.87 for the supply of Fycompa 2 mg tablets (30-count packages) under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order issued by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,148.08 by the Defense Logistics Agency on August 5, 2025, for the supply of Fycompa 4 mg tablets (30-count). This firm fixed-price delivery order, which concludes on August 6, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,111.20 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Fycompa 4 mg tablets (30-count units) with a ceiling value of $4,918.09. This firm fixed-price delivery order, which is scheduled for completion by September 22, 2025, represents a non-competitive award with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and is issued as a child...
- The Defense Logistics Agency awarded a $2,067.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count packaging) on July 10, 2025, with completion expected by July 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fycompa 8 mg tablets (30-count) with a ceiling value of $1,417.05. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location in the same...
- The Defense Logistics Agency awarded a $1,043.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 4 MG tablets (30-count units) with an ultimate completion date of October 24, 2025. This non-set-aside contract represents a competitively awarded purchase order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB26FHVUMDelivery Order
The Defense Logistics Agency awarded a $1,081.20 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Fycompa 8 mg tablets (30-count packaging). This delivery order, which serves as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA, is scheduled for completion by October 28, 2025, and represents part of the company's ongoing pharmaceutical distribution services to federal healthcare systems. The award was made through competitive procurement with no set-aside designation, consistent with AmerisourceBergen's typical federal contracting activity. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical through December 2026, which serves as the parent contract for this delivery order. This IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications for neurological, pain management, and other therapeutic needs. The company's federal procurement activity demonstrates its critical role as a pharmaceutical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/27/25 |